Vnitr Lek 2009, 55(5):523-528

Turner syndrome is associated with increased cardiovascular morbidity and mortality

M. Berková1,*, Z. Berka2, Z. Krčová3
1 I. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta prof. MUDr. Jan Lukl, CSc.
2 II. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Vlastimil Procházka, Ph.D.
3 Ústav patologie Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Martin Tichý, CSc.

The authors present a case of an acute myocardial infarction in a patient with Turner syndrome, leading to the death of the patient. An emphasis is put on the need of a thorough examination of cardiovascular system, specialized on congenital heart disease including aortic dilatation with the risk of dissection, and early development of ischemic heart disease. Regular monitoring as well as adequate therapy in patients suffering from this genetically determined disorder is recommended.

Keywords: Turner syndrome; ischemic heart disease; myocardial infarction; congenital heart disease

Received: October 31, 2008; Accepted: December 30, 2008; Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Berková M, Berka Z, Krčová Z. Turner syndrome is associated with increased cardiovascular morbidity and mortality. Vnitr Lek. 2009;55(5):523-528.
Download citation

References

  1. Elsheikh M, Dunger DB, Conway GS et al. Turner Syndrome in Adulthood. Endocrine Reviews 2002; 23: 120-140. Go to original source... Go to PubMed...
  2. Zapletalová J, Šnajderová M. Turnerův syndrome. Praha: Galén 2003: 149-159.
  3. Gravhold CH, Juul S, Naeraa RW et al. Morbidity in Turner syndrome. J Clin Epidemiol 1998; 51: 147-158. Go to original source... Go to PubMed...
  4. Ross JL, Feuillan P, Long LM et al. Lipid abnormalities in Turner syndrome. J Pediatr 1995; 126: 242-245. Go to original source... Go to PubMed...
  5. Garden AS, Diver MJ, Fraser WD. Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf) 1996; 45: 589-594. Go to original source... Go to PubMed...
  6. Gravholt CH, Naeraa RW, Nyholm B et al. Glucose metabolism, lipid metabolism and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes care 1998; 21: 1062-1070. Go to original source... Go to PubMed...
  7. Van Teunenbroek A, de Muinck Keizer Schrama SM, Aanstoot HJ et al. Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch working group on Growth Hormone. Metabolism 1999; 48: 7-14. Go to original source... Go to PubMed...
  8. Sylven L, Hagenfeldt K, Brondum-Nielsen K et al. Middle-aged women with Turner's syndrome. Medical status, hormonal treatment, and social life. Acta Endocrinol 1991; 125: 359-365. Go to original source... Go to PubMed...
  9. Lanes R, Gunczler P, Palacios A et al. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Fertil steril 1997; 68: 473-477. Go to original source... Go to PubMed...
  10. Ostberg JE, Donald AE, Halcox JPJ et al. Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal thickening without endothelial dysfunction. Clin Endocrinol Metabol 2005; 90: 5161-5166. Go to original source... Go to PubMed...
  11. Chlumský J, Kölbel F, Burešová M et al. Disekující aneuryzma aorty u nemocné s Turnerovým syndromem. Vnitř Lék 2000; 46: 34-36. Go to PubMed...
  12. Van PL, Bakalov V, Bondy CA. Monosomy for the X chromosome is associated with an atherogenic lipid profile. J Clin Endocrinol Metab 2006; 91: 2867-2870. Go to original source... Go to PubMed...
  13. Van PL, Bakalov V, Zinn A et al. Maternal X-chromosome, visceral adiposity and lipid profile. JAMA 2006; 295: 1373-1374. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.